الإعلام

الأخبار الصحفية

News, Wedge Networks

Wedge Networks invited to MobilityXlab program to co-create mobility solutions

Wedge Networks Inc. (Wedge) is invited to join MobilityXlab, a collaboration hub founded in 2017 by global companies to create and innovate future mobility solutions. Wedge will participate to co-create solutions for safe and secure mobility in partnership with seven world-leading industry partners: CEVT, Ericsson, Polestar, Veoneer, Volvo Cars, Volvo Group, and Zenseact.


Read More

News, Wedge Networks

Wedge Networks introduces a new generation of its Intelligent Web Shield™ (IWS) Solution to support SASE use cases

Wedge Networks Inc. (Wedge) is introducing a new generation of its Intelligent Web Shield™ (IWS) solution available to all customers and partners using WedgeARP™ v2.6 and above to support up and coming SASE use cases.   The ever-expanding SASE market is witnessing novel use cases such as 5G Edge/MEC services, smart infrastructure, smart manufacturing and CAV/ITS all of which require zero trust for both access and network traffic at the edge.


Read More

News, Wedge Networks

Wedge Networks announces issuance of new patent – U.S. Patent 11,349,852

Wedge Networks Inc. (Wedge) announced that the United States Patent and Trademark Office (USPTO) has awarded its technology with U.S. Patent 11,349,852, ascertaining Wedge Network’s unique value proposition and innovation.  This invention builds on Wedge’s previous network-based content inspection (NBCI) patent – USPTO #7,630,379.


Read More

Biotricity, News

Biotricity issues shareholder update

Biotricity Inc. (Biotricity) today provided an update for its shareholders by Chief Executive Officer Waqaas Al-Siddiq, Ph.D., that discusses recent company achievements and strategic initiatives to position the business for strong 2022 results, increasing scale and accelerating growth into 2023.


Read More

Biotricity, News

Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022

Biotricity Inc. (Biotricity) will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022.  The product has been available for pre-orders to physicians, medical offices, hospitals and individual use since late-February 2022.


Read More

Biotricity, News

Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022

Biotricity Inc. (Biotricity) has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022.  Biotricity was also highlighted as #1 in this year’s Medical Devices category.  This year’s list honors businesses that are making the biggest impact on their industries and culture as a whole-ultimately thriving in today’s ever-changing world.


Read More

1 2 7 8 9 10
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
موقع YouTube
Consent to display content from - Youtube
فيميو
Consent to display content from - Vimeo
خرائط جوجل
Consent to display content from - Google
سبوتيفي
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound